GTC Biotherapeutics (fka GTCB)

[waynebio]

<Such a negotiating tactic would incur a large risk of losing the deal altogether to another suitor.>

Perhaps the prospective partner is not worried about losing the deal by squeezing GTCB because there is only one prospective partner. The last 6 months has proven that there are not multiple partners stumbling over each other to make a generous deal with GTCB. It is not like GTCB is selling some high demand commodity here.

<Moreover, if “squeezing” were to hurt the prospective partner financially, it could backfire on the squeezer by lessening the productivity of the eventual partnership.>

Perhaps the partner would like to play the squeeze until GTCB gives up and agrees to a take over.